Explore

Trendline Trendline
NAD+ Supplements and Infusions: Examining the Longevity Claims

NAD+ Supplements and Infusions: Examining the Longevity Claims

NAD+ Supplements and Infusions: Examining the Longevity Claims
Trendline Trendline
Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership

Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership

Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership
Trendline Trendline
NAD+ Supplements Marketed for Longevity Amidst Scientific Skepticism

NAD+ Supplements Marketed for Longevity Amidst Scientific Skepticism

NAD+ Supplements Marketed for Longevity Amidst Scientific Skepticism
Trendline Trendline
Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences

Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences

Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences
Trendline Trendline
Niagen Bioscience to Participate in May 2026 Investor Conferences Highlighting NAD+ Research

Niagen Bioscience to Participate in May 2026 Investor Conferences Highlighting NAD+ Research

Niagen Bioscience to Participate in May 2026 Investor Conferences Highlighting NAD+ Research
Trendline Trendline
Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies
Trendline Trendline
Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus

Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus

Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus
Trendline Trendline
AN2 Therapeutics to Present at 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Present at 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Present at 2026 Stifel Virtual Targeted Oncology Forum
Trendline Trendline
Life Sciences Companies Invest in Longevity Research to Extend Healthspan

Life Sciences Companies Invest in Longevity Research to Extend Healthspan

Life Sciences Companies Invest in Longevity Research to Extend Healthspan
Trendline Trendline
Strength Coach Jack Hanrahan Sets Lower-Body Benchmarks for Men Over 40

Strength Coach Jack Hanrahan Sets Lower-Body Benchmarks for Men Over 40

Strength Coach Jack Hanrahan Sets Lower-Body Benchmarks for Men Over 40
Trendline Trendline
AbCellera to Present at Major Investor Conferences in May and June 2026

AbCellera to Present at Major Investor Conferences in May and June 2026

AbCellera to Present at Major Investor Conferences in May and June 2026
Trendline Trendline
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum